ID   IKKB_RAT                Reviewed;         757 AA.
AC   Q9QY78;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Inhibitor of nuclear factor kappa-B kinase subunit beta;
DE            Short=I-kappa-B-kinase beta;
DE            Short=IKK-B;
DE            Short=IKK-beta;
DE            Short=IkBKB;
DE            EC=2.7.11.10;
DE   AltName: Full=I-kappa-B kinase 2;
DE            Short=IKK2;
DE   AltName: Full=Nuclear factor NF-kappa-B inhibitor kinase beta;
DE            Short=NFKBIKB;
DE   AltName: Full=Serine/threonine protein kinase IKBKB;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:O14920};
GN   Name=Ikbkb; Synonyms=Ikkb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang Y., Sun S., Ravid K.;
RT   "IKK beta in megakaryocyte differentiation.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   IKK PHOSPHORYLATION.
RX   PubMed=9819420; DOI=10.1128/mcb.18.12.7336;
RA   Nemoto S., DiDonato J.A., Lin A.;
RT   "Coordinate regulation of IkappaB kinases by mitogen-activated protein
RT   kinase kinase kinase 1 and NF-kappaB-inducing kinase.";
RL   Mol. Cell. Biol. 18:7336-7343(1998).
RN   [3]
RP   INTERACTION WITH SQSTM1; PRKCI AND TRAF6.
RX   PubMed=16079148; DOI=10.1074/jbc.c500237200;
RA   Wooten M.W., Geetha T., Seibenhener M.L., Babu J.R., Diaz-Meco M.T.,
RA   Moscat J.;
RT   "The p62 scaffold regulates nerve growth factor-induced NF-kappaB
RT   activation by influencing TRAF6 polyubiquitination.";
RL   J. Biol. Chem. 280:35625-35629(2005).
RN   [4]
RP   REVIEW.
RX   PubMed=10712233; DOI=10.1152/ajpcell.2000.278.3.c451;
RA   Jobin C., Sartor R.B.;
RT   "The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation
RT   and protection.";
RL   Am. J. Physiol. 278:C451-C462(2000).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   INTERACTION WITH AKAP13.
RX   PubMed=23090968; DOI=10.1128/mcb.00887-12;
RA   del Vescovo C.D., Cotecchia S., Diviani D.;
RT   "A-kinase-anchoring protein-Lbc anchors IkappaB kinase beta to support
RT   interleukin-6-mediated cardiomyocyte hypertrophy.";
RL   Mol. Cell. Biol. 33:14-27(2013).
CC   -!- FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B
CC       signaling pathway which is activated by multiple stimuli such as
CC       inflammatory cytokines, bacterial or viral products, DNA damages or
CC       other cellular stresses. Acts as a part of the canonical IKK complex in
CC       the conventional pathway of NF-kappa-B activation. Phosphorylates
CC       inhibitors of NF-kappa-B on 2 critical serine residues. These
CC       modifications allow polyubiquitination of the inhibitors and subsequent
CC       degradation by the proteasome. In turn, free NF-kappa-B is translocated
CC       into the nucleus and activates the transcription of hundreds of genes
CC       involved in immune response, growth control, or protection against
CC       apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates
CC       several other components of the signaling pathway including NEMO/IKBKG,
CC       NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1
CC       and IKBKE. IKK-related kinase phosphorylations may prevent the
CC       overproduction of inflammatory mediators since they exert a negative
CC       regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-
CC       dependent inactivation of this pro-apoptotic transcription factor. Also
CC       phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1
CC       (By similarity). Phosphorylates RIPK1 at 'Ser-25' which represses its
CC       kinase activity and consequently prevents TNF-mediated RIPK1-dependent
CC       cell death (By similarity). Phosphorylates the C-terminus of IRF5,
CC       stimulating IRF5 homodimerization and translocation into the nucleus
CC       (By similarity). {ECO:0000250|UniProtKB:O14920,
CC       ECO:0000250|UniProtKB:O88351}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[I-kappa-B protein] = ADP + H(+) + O-phospho-L-
CC         seryl-[I-kappa-B protein]; Xref=Rhea:RHEA:19073, Rhea:RHEA-
CC         COMP:13698, Rhea:RHEA-COMP:13699, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421,
CC         ChEBI:CHEBI:456216; EC=2.7.11.10;
CC         Evidence={ECO:0000250|UniProtKB:O14920};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O14920};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:O14920};
CC   -!- SUBUNIT: Component of the I-kappa-B-kinase (IKK) core complex
CC       consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-
CC       beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The
CC       IKK core complex seems to associate with regulatory or adapter proteins
CC       to form a IKK-signalosome holo-complex. The IKK complex associates with
CC       TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of
CC       RELA/p65. Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB,
CC       IKBKG and CREBBP. Part of a 70-90 kDa complex at least consisting of
CC       CHUK/IKKA, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14. Found in a membrane
CC       raft complex, at least composed of BCL10, CARD11, DPP4 and IKBKB (By
CC       similarity). Interacts with SQSTM1 through PRKCZ or PRKCI
CC       (PubMed:16079148). Forms an NGF-induced complex with IKBKB, PRKCI and
CC       TRAF6 (PubMed:16079148). May interact with MAVS/IPS1. Interacts with
CC       NALP2. Interacts with TICAM1. Interacts with FAF1; the interaction
CC       disrupts the IKK complex formation. Interacts with ATM. Part of a
CC       ternary complex consisting of TANK, IKBKB and IKBKG. Interacts with
CC       NIBP; the interaction is direct. Interacts with ARRB1 and ARRB2.
CC       Interacts with TRIM21. Interacts with NLRC5; prevents IKBKB
CC       phosphorylation and kinase activity. Interacts with PDPK1. Interacts
CC       with EIF2AK2/PKR. The phosphorylated form interacts with PPM1A and
CC       PPM1B. Interacts with ZNF268 isoform 2; the interaction is further
CC       increased in a TNF-alpha-dependent manner. Interacts with IKBKE.
CC       Interacts with ZC3H12A (By similarity). Interacts with AKAP13
CC       (PubMed:23090968). Interacts with LRRC14; disrupts IKBKB-IKBKG
CC       interaction preventing I-kappa-B-kinase (IKK) core complex formation
CC       and leading to a decrease of IKBKB phosphorylation and NF-kappaB
CC       activation (By similarity). Interacts with SASH1 (By similarity).
CC       Interacts with ARFIP2 (By similarity). Interacts with FKBP5 (By
CC       similarity). {ECO:0000250|UniProtKB:O14920,
CC       ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:16079148,
CC       ECO:0000269|PubMed:23090968}.
CC   -!- INTERACTION:
CC       Q9QY78; O70377: Snap23; NbExp=2; IntAct=EBI-1812464, EBI-1573765;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O14920}. Nucleus
CC       {ECO:0000250|UniProtKB:O14920}. Membrane raft
CC       {ECO:0000250|UniProtKB:O14920}. Note=Colocalized with DPP4 in membrane
CC       rafts. {ECO:0000250|UniProtKB:O14920}.
CC   -!- DOMAIN: The kinase domain is located in the N-terminal region. The
CC       leucine zipper is important to allow homo- and hetero-dimerization. At
CC       the C-terminal region is located the region responsible for the
CC       interaction with NEMO/IKBKG. {ECO:0000250|UniProtKB:O14920}.
CC   -!- PTM: Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181
CC       by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances
CC       activity. Phosphorylated by MAP3K7/TAK1 in response to NOD1 and NOD2
CC       signaling, promoting activation and phosphorylation of NF-kappa-B
CC       inhibitors, leading to NF-kappa-B activation. Once activated,
CC       autophosphorylates on the C-terminal serine cluster; which decreases
CC       activity and prevents prolonged activation of the inflammatory
CC       response. Phosphorylated by the IKK-related kinases TBK1 and IKBKE,
CC       which is associated with reduced CHUK/IKKA and IKBKB activity and NF-
CC       kappa-B-dependent gene transcription. Dephosphorylated at Ser-177 and
CC       Ser-181 by PPM1A and PPM1B. {ECO:0000250|UniProtKB:O14920}.
CC   -!- PTM: Ubiquitinated. Monoubiquitination involves TRIM21 that leads to
CC       inhibition of Tax-induced NF-kappa-B signaling. 'Ser-163' may not serve
CC       as a monoubiquitination site. Ubiquitination on 'Ser-163' may modulate
CC       phosphorylation on C-terminal serine residues.
CC       {ECO:0000250|UniProtKB:O14920}.
CC   -!- PTM: Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic
CC       conditions results in activation of NF-kappa-B.
CC       {ECO:0000250|UniProtKB:O14920}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. I-kappa-B kinase subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF115282; AAF21978.1; -; mRNA.
DR   RefSeq; NP_445807.2; NM_053355.2.
DR   AlphaFoldDB; Q9QY78; -.
DR   SMR; Q9QY78; -.
DR   BioGRID; 249911; 2.
DR   CORUM; Q9QY78; -.
DR   IntAct; Q9QY78; 4.
DR   STRING; 10116.ENSRNOP00000025851; -.
DR   ChEMBL; CHEMBL4524001; -.
DR   iPTMnet; Q9QY78; -.
DR   PhosphoSitePlus; Q9QY78; -.
DR   PaxDb; 10116-ENSRNOP00000025851; -.
DR   GeneID; 84351; -.
DR   KEGG; rno:84351; -.
DR   UCSC; RGD:621375; rat.
DR   AGR; RGD:621375; -.
DR   CTD; 3551; -.
DR   RGD; 621375; Ikbkb.
DR   eggNOG; KOG4250; Eukaryota.
DR   InParanoid; Q9QY78; -.
DR   OrthoDB; 3949542at2759; -.
DR   PhylomeDB; Q9QY78; -.
DR   BRENDA; 2.7.11.10; 5301.
DR   Reactome; R-RNO-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-RNO-1810476; RIP-mediated NFkB activation via ZBP1.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-RNO-209560; NF-kB is activated and signals survival.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-RNO-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-RNO-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-RNO-5357956; TNFR1-induced NF-kappa-B signaling pathway.
DR   Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   Reactome; R-RNO-933542; TRAF6 mediated NF-kB activation.
DR   Reactome; R-RNO-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-RNO-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-RNO-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-RNO-9758274; Regulation of NF-kappa B signaling.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   Reactome; R-RNO-9860276; SLC15A4:TASL-dependent IRF5 activation.
DR   PRO; PR:Q9QY78; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0035631; C:CD40 receptor complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0008385; C:IkappaB kinase complex; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008384; F:IkappaB kinase activity; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:1990459; F:transferrin receptor binding; ISO:RGD.
DR   GO; GO:0001782; P:B cell homeostasis; ISO:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:RGD.
DR   GO; GO:1903347; P:negative regulation of bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:1903140; P:regulation of establishment of endothelial barrier; ISO:RGD.
DR   GO; GO:0061847; P:response to cholecystokinin; IDA:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0003009; P:skeletal muscle contraction; IEP:RGD.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   CDD; cd14038; STKc_IKK_beta; 1.
DR   CDD; cd17046; Ubl_IKKA_like; 1.
DR   Gene3D; 1.20.1270.250; -; 1.
DR   Gene3D; 6.10.250.2110; -; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR041185; IKBKB_SDD.
DR   InterPro; IPR046375; IKBKB_SDD_sf.
DR   InterPro; IPR051180; IKK.
DR   InterPro; IPR022007; IKKbetaNEMObind.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22969; IKB KINASE; 1.
DR   PANTHER; PTHR22969:SF7; INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE SUBUNIT BETA; 1.
DR   Pfam; PF18397; IKBKB_SDD; 1.
DR   Pfam; PF12179; IKKbetaNEMObind; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM01239; IKKbetaNEMObind; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Hydroxylation; Isopeptide bond; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   S-nitrosylation; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..757
FT                   /note="Inhibitor of nuclear factor kappa-B kinase subunit
FT                   beta"
FT                   /id="PRO_0000086015"
FT   DOMAIN          15..300
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          458..479
FT                   /note="Leucine-zipper"
FT   REGION          682..703
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          737..742
FT                   /note="NEMO-binding"
FT   COMPBIAS        682..698
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        145
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         21..29
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         44
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         177
FT                   /note="Phosphoserine; by TBK1 and PKC/PRKCZ"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         179
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         181
FT                   /note="Phosphoserine; by TBK1, PKC/PRKCZ and PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         191
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         670
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         672
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         675
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         682
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         689
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         692
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         697
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         705
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         733
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   MOD_RES         740
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O14920"
SQ   SEQUENCE   757 AA;  86866 MW;  3AFFE46A7DF91F9C CRC64;
     MSWSPSLPTQ TCGAWEMKER LGTGGFGNVI RWHNQVTGEQ IAIKQCRQEL SPKNRDRWCL
     EIQIMRRLNH PNVVAARDVP EGMQNLAPND LPLLAMEYCQ GGDLRRYLNQ FENCCGLREG
     AILTLLSDIA SALRYLHENR IIHRDLKPEN IVLQQGEKRL IHKIIDLGYA KELDQGSLCT
     SFVGTLQYLA PELLEQQKYT VTVDYWSFGT LAFECITGFR PFLPNWQPVQ WHSKVRQKSE
     VDIVVSEDLN GTVKFSSSSP FPNNLNSVLA ERLEKWLQLM LTWQPRQRGV DPQYGPNGCF
     RALDDILNLK LVHILNMVTG TIHTYPVMED ESLQSLKTRI REDTGILETD QELLQEAGLV
     LLPDKPATQC ISDSKTNEGL TLDMDLVFLF DNSKMSYETQ ITPRPQPESV SCVLQEPKRN
     LSFFQMRKVW GQVWHSIQTL KEDCNRLQQG QRAAMMNLLR NNSCLSKMKN AMASTAQQLK
     AKLDFFKTSI QIDLEKYREQ TEFGITSDKL LLAWREMEQA VEQCGRENDV KVLVERMMAL
     QTDIVDLQRS PMGRKQGGTL DDLEEQAREL YRRLREKPRD QRTEGDSQDM VRLLLQAIQS
     FEKKVRVIYS QLSKTVVCKQ KALELLPKVE EVVRLMNEDE KTVVRLQEKR QKELWNLLKI
     ACSKVRGPVS GSPDSMNVSR LSHPGHLMSQ PSSACDSLPD SDKKSEELVA EAHALCSRLE
     SALQDTVKQQ DRSFTTLDWS WLQMEDEERC GLEQACD
//
